you are here: Home News Sanofi

Sanofi

Dr Reddy's to introduce Sanofi's novel drug in India
Sanofi gets CDSCO nod for Beyfortus India
Sanofi to invest Euro 400 million in its Hyderabad GCC by 2030
Lupin arm completes acquisition of two brands from Sanofi
Novavax shares soar on license deal with Sanofi at lofty valuation
Sanofi introduces diabetes drug Soliqua in India
Dr Reddy's inks distribution agreement for Sanofi vaccines in India
Sanofi ties up with Emcure to broaden reach of cardiovascular brands
Lupin to acquire established products in Europe, Canada from Sanofi for Rs 91 cr
CORONA Remedies acquires Sanofi India's Myoril brand for Rs 234 crore
Sanofi to widen presence in India with more products: MD Rodolfo Hrosz
Sanofi to let go of staff at vaccine plants in India as part of review
Amgen is said to agree to buy horizon at $26 billion valuation
Sanofi, GSK Covid-19 vaccine found effective against Omicron
Sanofi says COVID-19 vaccine candidate yields positive trial data
Sanofi India MD Rajaram Narayanan resigns
Sanofi to buy US biotech firm Amunix for $1 billion
Sanofi, GSK get approval to conduct phase 3 trial of COVID-19 vaccine in India
COVID-19 vaccine | Sanofi to seek permission for Phase 3 trial in India: Report
Sanofi to invest 400 million euros in a mRNA vaccines facility
Another COVID-19 vaccine enters final trials
COVID-19 Vaccine | Sanofi and GSK’s vaccine said to produce strong immune responses in mid-stage study
Sanofi to produce Moderna coronavirus vaccine
Sanofi to start human trials of its second COVID vaccine candidate
GSK, Sanofi begin new COVID-19 vaccine trial after setback last year

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Sanofi

Dr Reddy's to introduce Sanofi's novel drug in India

Sanofi gets CDSCO nod for Beyfortus India

Sanofi to invest Euro 400 million in its Hyderabad GCC by 2030

Lupin arm completes acquisition of two brands from Sanofi

Novavax shares soar on license deal with Sanofi at lofty valuation

Sanofi introduces diabetes drug Soliqua in India

Dr Reddy's inks distribution agreement for Sanofi vaccines in India

Sanofi ties up with Emcure to broaden reach of cardiovascular brands

Lupin to acquire established products in Europe, Canada from Sanofi for Rs 91 cr

CORONA Remedies acquires Sanofi India's Myoril brand for Rs 234 crore

Sanofi to widen presence in India with more products: MD Rodolfo Hrosz

Sanofi to let go of staff at vaccine plants in India as part of review

Amgen is said to agree to buy horizon at $26 billion valuation

Sanofi, GSK Covid-19 vaccine found effective against Omicron

Sanofi says COVID-19 vaccine candidate yields positive trial data

Sanofi India MD Rajaram Narayanan resigns

Sanofi to buy US biotech firm Amunix for $1 billion

Sanofi, GSK get approval to conduct phase 3 trial of COVID-19 vaccine in India

COVID-19 vaccine | Sanofi to seek permission for Phase 3 trial in India: Report

Sanofi to invest 400 million euros in a mRNA vaccines facility

Another COVID-19 vaccine enters final trials

COVID-19 Vaccine | Sanofi and GSK’s vaccine said to produce strong immune responses in mid-stage study

Sanofi to produce Moderna coronavirus vaccine

Sanofi to start human trials of its second COVID vaccine candidate

GSK, Sanofi begin new COVID-19 vaccine trial after setback last year